References
Goossens H, Ferech M, Vander Stichele R et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.Lancet. 2005 Feb 12–18; 365(9459): 548–9.
Johnson JR. Fluoroquinolones in urinary tract infection. Milestones in drug therapy: Fluoroquinolone antibiotics 2003 Birkhauser: 107–19.
Preiksaitis JK, Thompson L, Harding GK et al. A comparison of the efficacy of nalidixic acid and cephalexin in bacteriuric women and the effect on fecal and periurethral carriage of enterobacteriaceae.J Infect Dis 1981; 143 (4): 603–8.
Stamm WE, McKevitt M, Counts GW. Acute renal infection in women: treatment with trimethoprim-sulfamethoxazole or ampicillin for two or six weeks. A randomized trial.Ann Intern Med. 1987 Mar;106(3): 341–5.
Hooton TM, Scholes D, Gupta K, et al. Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial.JAMA 2005; 293: 949–55.
Karlowsky JA, Kelly LJ, Thornsberry C et al. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States.Antimicrob Agents Chemother. 2002 Aug; 46(8): 2540–5.
Goettscha W, van Pelta W, Nagelkerkea N et al. Increasing resistance to fluoroquinolones inEscherichia coli from urinary tract infections in The NetherlandsJ Antimicrob Chemother. 2000 Aug; 46(2): 223–8.
Fadda G, Nicoletti G, Schito GC et al. Antimicrobial susceptibility patterns of contemporary pathogens from uncomplicated urinary tract infections isolated in a multicenter Italian survey: possible impact on guidelines.J Chemother. 2005 Jun; 17(3): 251–7.
Karaca Y, Coplu N, Gozalan A et al. Co-trimoxazole and quinolone resistance in Escherichia coli isolated from urinary tract infections over the last 10 years.Int J Antimicrob Agents 2005 Jul; 26(1): 75–7.
Andreu A, Alos JI, Gobernado M et al. Aetiology and antimicrobial susceptibility among uropathogens causing community-acquired lower urinary tract infections: a nationwide surveillance study.Enferm Infect Microbiol Clin. 2005 Jan; 23(1): 4–9.
Sheehan G, Chew N. The history of quinolones. Milestones in drug therapy: Fluoroquinolone antibiotics. 2003 Birkhauser: 1–10.
Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECOSENS Project.J Antimicrob Chemother. 2003 Jan; 51(1): 69–76.
Alos JI, Serrano MG, Gomez-Garces JL, Perianes J. Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data.Clin Microbiol Infect. 2005 Mar; 11(3): 199–203.
Sobel J, Kaye D. Urinary tract infections. Mandell, Douglas and Bennett’s Principles and practice of infectious diseases. 2005, 6th Edition; Chapter 66: 875–905.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sheehan, G., Chew, N. Anti-microbial stewardship for urinary tract infection. Ir J Med Sci 174, 3–5 (2005). https://doi.org/10.1007/BF03168973
Issue Date:
DOI: https://doi.org/10.1007/BF03168973